Marcelo Kugelmas - Publications

Journal: Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Published: January 27, 2021

Filters

Safety and efficacy of elafibranor in primary sclerosing cholangitis: The ELMWOOD phase II randomized-controlled trial.

Safety and efficacy of elafibranor in primary sclerosing cholangitis: The ELMWOOD phase II randomized-controlled trial.

Improving Outcomes in Hepatorenal Syndrome-Acute Kidney Injury With Early Diagnoses and Implementation of Approved Treatment Regimens.

Improving Outcomes in Hepatorenal Syndrome-Acute Kidney Injury With Early Diagnoses and Implementation of Approved Treatment Regimens.

The impact of stigma on quality of life and liver disease burden among patients with nonalcoholic fatty liver disease.

The impact of stigma on quality of life and liver disease burden among patients with nonalcoholic fatty liver disease.

Global survey of stigma among physicians and patients with nonalcoholic fatty liver disease.

Global survey of stigma among physicians and patients with nonalcoholic fatty liver disease.

Expert perspectives for the pharmacist on facilitating and improving the use of albumin in cirrhosis.

Expert perspectives for the pharmacist on facilitating and improving the use of albumin in cirrhosis.

The use of current knowledge and non-invasive testing modalities for predicting at-risk non-alcoholic steatohepatitis and assessing fibrosis.

The use of current knowledge and non-invasive testing modalities for predicting at-risk non-alcoholic steatohepatitis and assessing fibrosis.

Liver Cirrhosis Increases the Risk of Developing Advanced Colon Polyps.

Liver Cirrhosis Increases the Risk of Developing Advanced Colon Polyps.

Clinical and Patient-Reported Outcomes From Patients With Nonalcoholic Fatty Liver Disease Across the World: Data From the Global Non-Alcoholic Steatohepatitis (NASH)/ Non-Alcoholic Fatty Liver Disease (NAFLD) Registry.

Clinical and Patient-Reported Outcomes From Patients With Nonalcoholic Fatty Liver Disease Across the World: Data From the Global Non-Alcoholic Steatohepatitis (NASH)/ Non-Alcoholic Fatty Liver Disease (NAFLD) Registry.

A Global Survey of Physicians Knowledge About Nonalcoholic Fatty Liver Disease.

A Global Survey of Physicians Knowledge About Nonalcoholic Fatty Liver Disease.

The Current Management of Hepatorenal Syndrome-Acute Kidney Injury in the United States and the Potential of Terlipressin.

The Current Management of Hepatorenal Syndrome-Acute Kidney Injury in the United States and the Potential of Terlipressin.

Treatment Options for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing a Scheduled Procedure.

Treatment Options for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing a Scheduled Procedure.

Financial Compensation For Hepatologists in Different Practice Settings.

Financial Compensation For Hepatologists in Different Practice Settings.